History of Drew Quality Group, Inc.
In 2013 Deborah Drew and had been working in the pharmaceutical industry for 23
years. She and some of her fellow engineers and scientists had each spent twenty years
or more working for some of the largest drug companies in America. These men and
women were drawn to working for these companies due to their critical work in
reducing suffering and transforming lives.
But, over time, they had each seen these corporations become more and more
consumed by their need to make an ever-increasing amount of profit for their
stockholders. These professionals felt that the mission of their company's had become
co-opted. Some of the older, low-cost drugs that these companies had produced for
years—drugs that are essential for particular patients—were discontinued to make way
for new, higher-priced patented drugs. As a result, over 70 drugs are in shortage today;
drug pricing is no longer assured, and uncertainty plagues hospitals and clinics across
On April 2, 2014, Deborah Drew and four of her colleagues founded Drew Quality
Group, Inc.—the first nonprofit 501(c)3 generic drug manufacturing company in the
United States. They are committed to manufacturing a number of the drugs on the
FDA's Drug Shortage List, including those discontinued older drugs that are needed by a
small number of patients for a particular disease or condition. And, when feasible, DQG
will directly compete with those sole manufacturers of a given generic drug who are
taking advantage of their situation and gouging the public.